Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01007357 · ClinicalTrials.gov registry record · NA
Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation
A NA study, sponsored by University of Nebraska.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT01007357: Clinical Trial NA study, sponsored by University of Nebraska.
NCT01007357 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01007357, a NA study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This project will facilitate the optimization of body MR imaging at 3 Tesla.
Primary Outcome
Healthy volunteers will be used to obtain optimized body MR imaging sequences that will then be used to evaluate MR imaging sequences of subjects with underlying disorders.
Interventions
- DEVICE Body MR imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-12-15 |
| Est. Completion | 2015-06-30 |
| Phase | NA |
Why NCT01007357 stopped before completion
NCT01007357 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Body MR imaging is the first listed.
NCT01007357 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01007357 about?
NCT01007357 is a clinical study titled "Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation". This project will facilitate the optimization of body MR imaging at 3 Tesla.
What is the current status of trial NCT01007357?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2009-12-15. Estimated completion is 2015-06-30.
What interventions are being tested in trial NCT01007357?
The interventions under investigation include: Body MR imaging (DEVICE).
Who is sponsoring clinical trial NCT01007357?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01007357's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI